Home › Therapeutic areas › Cardiovascular › Catecholaminergic Polymorphic Ventricular Tachycardia
Catecholaminergic Polymorphic Ventricular Tachycardia (1 companies)
Companies with an active program in Catecholaminergic Polymorphic Ventricular Tachycardia.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| SLDB | Solid Biosciences | CardiovascularNeurology Rare | 1 | Phase 3 | $736M | 6 |
No companies match.